Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial

OBJECTIVE: Prostate cancer is a disease of older men. Weekly docetaxel (DPq1w) is often favored over the standard three-weekly regimen (DPq3w) due to concerns about safety and tolerability in this population. MATERIALS AND METHODS: Two subgroup analyses of TAX 327 were conducted. Among patients rece...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Geriatr Oncol
Auteurs principaux: Horgan, Anne M., Seruga, Bostjan, Pond, Greg R., Alibhai, Shabbir M., Amir, Eitan, De Wit, Ronald, Eisenberger, Mario A., Tannock, Ian F.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352315/
https://ncbi.nlm.nih.gov/pubmed/24495703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2013.12.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires